Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

DE:978 Stock Latest News

The FlyAdagene doses first patient in muzastotug, INCA33890 combination study5d agoADAG

Company AnnouncementsAdagene Announces Finance Executive Resignation Effective September 30, 20261M ago6K ADAG
Company AnnouncementsAdagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG1381M ago6K ADAG
The FlyAdagene announces China’s NMPA approved IND for ADG1381M agoADAG
RatingsAdagene’s Platform Partnerships and Muzastotug Catalysts Support Buy Rating, Price Target Unchanged at $81M agoADAG

Adagene Deepens Third Arc Bio Partnership as First SAFEbody-Based CD3 Lead Selected

Company AnnouncementsAdagene Deepens Third Arc Bio Partnership as First SAFEbody-Based CD3 Lead Selected1M ago6K ADAG

The FlyAdagene initiated with a Buy at Chardan1M agoADAG

Company AnnouncementsAdagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration1M ago6K ADAG

The FlyAdagene announces $2M milestone payment from Exelixis1M agoADAG EXEL
Company AnnouncementsAdagene Extends Cash Runway and Advances Muzastotug Through Mid-2026 Clinical Milestones2M ago6K ADAG
Company AnnouncementsAdagene Discloses Preliminary US$127.9 Million Cash Balance as of June 30, 20263M ago6K ADAG
RatingsAnalyst Initiates Buy on Muza Developer, Citing Promising MSS CRC Data, Clear Registrational Path, and Broader Expansion Upside Despite Cash Constraints6M agoADAG

Adagene Showcases Promising Muzastotug Triplet Data at AACR 2026 for Liver and Colorectal Cancers

Company AnnouncementsAdagene Showcases Promising Muzastotug Triplet Data at AACR 2026 for Liver and Colorectal Cancers6M ago6K ADAG

The FlyAdagene presents data from two Phase 1b/2 studies of muzastotug at AACR6M agoADAG

RatingsAdagene: Deepening Dose‑Response Evidence and Strategic Partnership Support Buy Rating on Lead CTLA‑4 Program6M agoADAG

The FlyAdagene price target raised to $10 from $9 at Guggenheim7M agoADAG
The FlyAdagene 18.666M share Spot Secondary priced at $3.757M agoADAG
The FlyAdagene enters pact with Incyte for combination of muzastotug, INCA338907M agoADAG
The FlyAdagene announces results from the latest data cut of muzastotug study7M agoMRK ADAG

Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer

Company AnnouncementsAdagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer7M ago6K ADAG

Company AnnouncementsAdagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline7M ago6K ADAG

Company AnnouncementsAdagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 20287M ago6K ADAG